Anacetrapib: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Robert Badgett
(New page: In health care, '''anacetrapib''' (anacet'rapib) is a oxazolidinone medication that is a cholesteryl ester transfer protein inhibitor that raises HDL cholesterol and reduces [[...)
 
imported>Daniel Mietchen
m ({{subpages}})
Line 1: Line 1:
In [[health care]], '''anacetrapib''' (anacet'rapib) is a oxazolidinone [[medication]] that is a cholesteryl ester transfer protein inhibitor that raises [[HDL cholesterol]] and reduces [[LDL cholesterol]].<ref>{{MeSH}}</ref>
{{subpages}}
 
In [[health care]], '''anacetrapib''' (anacet'rapib) is an oxazolidinone [[medication]] that is a cholesteryl ester transfer protein inhibitor that raises [[HDL cholesterol]] and reduces [[LDL cholesterol]].<ref>{{MeSH}}</ref>


Anacetrapib is related to [[torcetrapib]].<ref name="pmid21082868">{{cite journal| author=Cannon CP, Shah S, Dansky HM, Davidson M, Brinton EA, Gotto AM et al.| title=Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease. | journal=N Engl J Med | year= 2010 | volume=  | issue=  | pages=  | pmid=21082868 | doi=10.1056/NEJMoa1009744 | pmc= | url= }} </ref>
Anacetrapib is related to [[torcetrapib]].<ref name="pmid21082868">{{cite journal| author=Cannon CP, Shah S, Dansky HM, Davidson M, Brinton EA, Gotto AM et al.| title=Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease. | journal=N Engl J Med | year= 2010 | volume=  | issue=  | pages=  | pmid=21082868 | doi=10.1056/NEJMoa1009744 | pmc= | url= }} </ref>

Revision as of 08:31, 22 November 2010

This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

In health care, anacetrapib (anacet'rapib) is an oxazolidinone medication that is a cholesteryl ester transfer protein inhibitor that raises HDL cholesterol and reduces LDL cholesterol.[1]

Anacetrapib is related to torcetrapib.[2]

References

  1. Anonymous (2024), Anacetrapib (English). Medical Subject Headings. U.S. National Library of Medicine.
  2. Cannon CP, Shah S, Dansky HM, Davidson M, Brinton EA, Gotto AM et al. (2010). "Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease.". N Engl J Med. DOI:10.1056/NEJMoa1009744. PMID 21082868. Research Blogging.